Victory Capital Management
SRRA

Victory Capital Management’s Sierra Oncology, Inc. Common Stock SRRA Stock Holding History

Victory Capital Management’s Portfolio SRRA Stock Details SRRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-2,954
Closed -$30K – 3560
2020
Q1 		$30K Buy
+2,954
New +$38.7K ﹤0.01% 2967
2019
Q4 		– Sell
-276
Closed -$4K – 3544
2019
Q3 		$4K Buy
+276
New +$5.28K ﹤0.01% 3534

Other funds holding SRRA

VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
A
Abingworth London, United Kingdom $307M AUM 93.47% 1-Year Est. Return
CC
Caxton Corporation Princeton, New Jersey $4.02M AUM 256.08% 1-Year Est. Return
MP
Mangrove Partners Greenwich, Connecticut $1.24B AUM 41.74% 1-Year Est. Return
NLVP
New Leaf Venture Partners New York $43M AUM 25.55% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
FM
Frazier Management Seattle, Washington $1.12M AUM 151.58% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Victory Capital Management's SRRA Position: Q2 2020 in Review

Victory Capital Management sold out of Sierra Oncology, Inc. Common Stock (SRRA) in Q2 2020, closing a stake of 2,954 shares — an estimated $30K sold.

Victory Capital Management first reported a position in SRRA in Q3 2019 and held it in 2 quarters. The position peaked at $30K in Q1 2020. 26 funds tracked by Wall St. Rank hold SRRA as of Q2 2020.

  • Victory Capital Management reported no remaining Sierra Oncology, Inc. Common Stock position as of Q2 2020 after selling out during the quarter.
  • Victory Capital Management sold 2,954 Sierra Oncology, Inc. Common Stock shares in Q2 2020, an estimated $30K.
  • Victory Capital Management first reported a position in Sierra Oncology, Inc. Common Stock in Q3 2019 and held it in 2 quarters.
  • Victory Capital Management's Sierra Oncology, Inc. Common Stock position peaked at $30K in Q1 2020.
  • 26 funds tracked by Wall St. Rank held Sierra Oncology, Inc. Common Stock as of Q2 2020.

Based on Victory Capital Management's 13F filing for Q2 2020, filed 7 Aug 2020.